FP611
3627
Dr.SHUBHANGI TANAJI SHEVALE
Membership No | Author Name | Mobile | |
---|---|---|---|
3627 | Dr.SHUBHANGI TANAJI SHEVALE | [email protected] | 9987602209 |
Refractive Surgery
Long Term Visual And Refractive Outcomes Of Eyecryl® Phakic IOL For High Myopia & Myopic Astigmatism
Purpose:To evaluate the long term outcomes of Eyecryl phakic IOL (pIOL) for high myopia and myopic astigmatism. Methods:Electronic Medical records of patients with Eyecryl pIOL or Eyecryl phakic Toric IOL(EPTIOL) from Aug 2017 to July 2022 were retrospectively reviewed. Results:A total of 186 eyes from 106 patients were analysed.Thirty three spherical and 153 EPTIOL were implanted.Mean follow up was 37.04±13.60 months.The pre-op sphere, cylinder, SE reduced from -9.91 ±5.22 D, -1.67±1.15 D & -10.75 ± 5.35 D to -0.03± 0.29D, -0.09± 0.32D, -0.07 ± 0.35D respectively(p-value>0.05). The mean efficacy & safety indices were 1.02 and 1.01 respectively. The mean vault was 497.86±167.75µ at 2 weeks, which reduced to 481.49±162.07 µ at 3.08 years,( p- <0.001). Endothelial cell loss was 2.4 % in the first 12 months.Two eyes of EPTIOL required realignment. Conclusion: Eyecryl pIOL implantation was found to be safe and effective surgical procedure for correction of high myopia & myopic astigmatism.
Membership No | Author Name | Mobile | |
---|---|---|---|
2404 | Dr.Sheetal Maharishi | [email protected] | 9591002092 |
262 | Dr.Sri Ganesh | [email protected] | 9845129740 |